These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33954875)

  • 1. Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer.
    Okugawa Y; Toiyama Y; Fujikawa H; Kawamura M; Yasuda H; Yokoe T; Mochiki I; Okita Y; Ohi M; Nakatani K
    Surg Today; 2021 Dec; 51(12):1906-1917. PubMed ID: 33954875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.
    Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Yokoe T; Saigusa S; Tanaka K; Shirai Y; Kobayashi M; Ohi M; Araki T; McMillan DC; Miki C; Goel A; Kusunoki M
    Ann Surg; 2020 Aug; 272(2):342-351. PubMed ID: 32675548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of the preoperative lymphocyte to C-reactive protein ratio in patients with stage III colorectal cancer.
    Eren T
    ANZ J Surg; 2022 Oct; 92(10):2585-2594. PubMed ID: 35779019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer.
    Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ichikawa T; Yin C; Suzuki A; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; McMillan DC; Kusunoki M
    Clin Nutr; 2020 Apr; 39(4):1209-1217. PubMed ID: 31155370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
    Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role and clinical significance of C-reactive protein-lymphocyte ratio in colorectal cancer.
    Meng Y; Long C; Huang X; Huang L; Liao L; Tang W; Liu J
    Bioengineered; 2021 Dec; 12(1):5138-5148. PubMed ID: 34436973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
    Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Potential of Lymphocyte-C-Reactive Protein Ratio in Patients with Rectal Cancer Receiving Preoperative Chemoradiotherapy.
    Okugawa Y; Toiyama Y; Fujikawa H; Ide S; Yamamoto A; Omura Y; Yin C; Kusunoki K; Kusunoki Y; Yasuda H; Yokoe T; Hiro J; Ohi M; Kusunoki M
    J Gastrointest Surg; 2021 Feb; 25(2):492-502. PubMed ID: 32040814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical feasibility of the preoperative C-reactive protein-albumin-lymphocyte index to predict short- and long-term outcomes of patients with gastric cancer.
    Okugawa Y; Ohi M; Kitajima T; Higashi K; Sato Y; Yamashita S; Uratani R; Shimura T; Imaoka H; Kawamura M; Koike Y; Yasuda H; Yoshiyama S; Okita Y; Toiyama Y
    J Gastrointest Surg; 2024 Jul; 28(7):1045-1050. PubMed ID: 38641163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of the preoperative lymphocyte C-reactive protein ratio in esophageal cancer patients.
    Yamamoto A; Toiyama Y; Okugawa Y; Ichikawa T; Imaoka H; Yasuda H; Fujikawa H; Okita Y; Yokoe T; Ohi M
    Surg Today; 2021 May; 51(5):745-755. PubMed ID: 33130991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
    Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
    BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of Preoperative Lymphocyte-to-C-Reactive Protein Ratio in Patients with Non-Metastatic Colorectal Cancer.
    Ou W; Zhou C; Zhu X; Lin L; Xu Q
    Onco Targets Ther; 2021; 14():337-346. PubMed ID: 33469310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative lymphocyte/C-reactive protein ratio and its correlation with CD8
    Miyazaki K; Morine Y; Imura S; Ikemoto T; Saito Y; Yamada S; Tokuda K; Okikawa S; Yamashita S; Oya T; Tsuneyama K; Shimada M
    Surg Today; 2021 Dec; 51(12):1985-1995. PubMed ID: 34009433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of nutritional risk and systemic inflammation with survival in patients with colorectal cancer who underwent curative surgery.
    Nakamura Y; Imada A; Fukugaki A; Kanto S; Yamaura T; Kinjo Y; Kuroda N
    Clin Nutr ESPEN; 2022 Jun; 49():417-424. PubMed ID: 35623847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative C-reactive Protein in the Perioperative Period as a Novel Marker for Oncological Outcome in Patients with Colorectal Cancer Undergoing Curative Resection.
    Fujikawa H; Okugawa Y; Yamamoto A; Imaoka H; Shimura T; Kitajima T; Kawamura M; Yasuda H; Okita Y; Yokoe T; Ohi M; Toiyama Y
    J Anus Rectum Colon; 2021; 5(3):281-290. PubMed ID: 34395941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Absolute Lymphocyte Count to Carcinoembryonic Antigen Ratio Is a Superior Predictor of Survival in Stage I to III Colorectal Cancer.
    Zhou Y; Cheng F; Zhang Z; Xiang J; Xue T; Ye Q; Yan B
    Clin Med Insights Oncol; 2022; 16():11795549221126249. PubMed ID: 36186673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
    BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients.
    Yasui K; Shida D; Nakamura Y; Ahiko Y; Tsukamoto S; Kanemitsu Y
    Br J Cancer; 2021 Mar; 124(5):933-941. PubMed ID: 33257844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between Prognostic Nutritional Index, Glasgow Prognostic Score, Systemic Inflammatory Response, and TNM Staging in Colorectal Cancer Patients.
    Bai X; Feng L
    Nutr Cancer; 2020; 72(7):1170-1177. PubMed ID: 31630565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.